Another important fact is that RAD001 is known to activate insulin receptor substrate 1 (IRS-1)-Akt signaling [16], [17], which is suggested to potentially attenuate its effects on tumor cell proliferation and viability [17]. This evidence concerns the gene AKT1 and neoplasm.